Transphorm, Inc.
TGAN
$4.85
$0.020.41%
| Weiss Ratings | TGAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | TGAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | TGAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.82 | |||
| Price History | TGAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -1.64% | |||
| 60-Day Total Return | -0.83% | |||
| 90-Day Total Return | 47.24% | |||
| Year to Date Total Return | 20.30% | |||
| 1-Year Total Return | 77.12% | |||
| 2-Year Total Return | -31.43% | |||
| 3-Year Total Return | -4.00% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -2.62% | |||
| 52-Week Low % Change | 148.97% | |||
| Price | TGAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $4.96 | |||
| 52-Week Low Price | $1.94 | |||
| 52-Week Low Price (Date) | Oct 04, 2023 | |||
| 52-Week High Price (Date) | Feb 09, 2024 | |||
| Valuation | TGAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 303.09M | |||
| Enterprise Value | 297.51M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.70 | |||
| Earnings Per Share Growth | 44.15% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 15.88 | |||
| Price/Book (Q) | 16.59 | |||
| Enterprise Value/Revenue (TTM) | 16.00 | |||
| Price | $4.80 | |||
| Enterprise Value/EBITDA (TTM) | -10.29 | |||
| Enterprise Value/EBIT | -9.89 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | TGAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 62.18M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TGAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 805 456 1300 | |||
| Address | 75 Castilian Drive Goleta, CA 93117 | |||
| Website | www.transphormusa.com | |||
| Country | United States | |||
| Year Founded | 2007 | |||
| Profitability | TGAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -161.73% | |||
| Profit Margin | -177.90% | |||
| Management Effectiveness | TGAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -46.29% | |||
| Return on Equity | -- | |||
| Income Statement | TGAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 18.76M | |||
| Total Revenue (TTM) | 18.76M | |||
| Revenue Per Share | $0.30 | |||
| Gross Profit (TTM) | 3.51M | |||
| EBITDA (TTM) | -29.17M | |||
| EBIT (TTM) | -30.33M | |||
| Net Income (TTM) | -33.37M | |||
| Net Income Avl. to Common (TTM) | -33.37M | |||
| Total Revenue Growth (Q YOY) | 3.94% | |||
| Earnings Growth (Q YOY) | 4.39% | |||
| EPS Diluted (TTM) | -0.70 | |||
| EPS Diluted Growth (Q YOY) | -10.95% | |||
| Balance Sheet | TGAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 7.95M | |||
| Cash Per Share (Q) | $0.13 | |||
| Total Current Assets (Q) | 20.95M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 18.25M | |||
| Current Ratio (Q) | 1.688 | |||
| Book Value Per Share (Q) | $0.29 | |||
| Total Assets (Q) | 32.66M | |||
| Total Current Liabilities (Q) | 12.41M | |||
| Total Debt (Q) | 2.37M | |||
| Total Liabilities (Q) | 14.41M | |||
| Total Common Equity (Q) | 18.25M | |||
| Cash Flow | TGAN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -3.44M | |||
| Cash from Financing (TTM) | 10.11M | |||
| Net Change in Cash (TTM) | -15.70M | |||
| Levered Free Cash Flow (TTM) | -10.01M | |||
| Cash from Operations (TTM) | -22.29M | |||
